Articles with public access mandates - Shruti SharmaLearn more
Available somewhere: 12
Analysis of plasma cell-free DNA by ultradeep sequencing in patients with stages I to III colorectal cancer
T Reinert, TV Henriksen, E Christensen, S Sharma, R Salari, H Sethi, ...
JAMA oncology 5 (8), 1124-1131, 2019
Mandates: Danish Council for Independent Research, Danish Council for Strategic Research
Early detection of metastatic relapse and monitoring of therapeutic efficacy by ultra-deep sequencing of plasma cell-free DNA in patients with urothelial bladder carcinoma
E Christensen, K Birkenkamp-Demtröder, H Sethi, S Shchegrova, R Salari, ...
Journal of Clinical Oncology 37 (18), 1547-1557, 2019
Mandates: Danish Council for Independent Research
Circulating tumor DNA in stage III colorectal cancer, beyond minimal residual disease detection, towards assessment of adjuvant therapy efficacy and clinical behavior of …
TV Henriksen, N Tarazona, A Frydendahl, T Reinert, F Gimeno-Valiente, ...
Clinical Cancer Research, 2021
Mandates: Government of Spain
Final results of neoadjuvant atezolizumab in cisplatin-ineligible patients with muscle-invasive urothelial cancer of the bladder
B Szabados, M Kockx, ZJ Assaf, PJ van Dam, A Rodriguez-Vida, I Duran, ...
European Urology 82 (2), 212-222, 2022
Mandates: Cancer Research UK
Impact of Circulating Tumor DNA–Based Detection of Molecular Residual Disease on the Conduct and Design of Clinical Trials for Solid Tumors
PM Kasi, G Fehringer, H Taniguchi, N Starling, Y Nakamura, D Kotani, ...
JCO Precision Oncology 6, e2100181, 2022
Mandates: US National Institutes of Health
Widely divergent transcriptional patterns between SLE patients of different ancestral backgrounds in sorted immune cell populations
S Sharma, Z Jin, E Rosenzweig, S Rao, K Ko, TB Niewold
Journal of autoimmunity 60, 51-58, 2015
Mandates: US National Institutes of Health
B-cell lymphoma patient-derived xenograft models enable drug discovery and are a platform for personalized therapy
L Zhang, K Nomie, H Zhang, T Bell, L Pham, S Kadri, J Segal, S Li, ...
Clinical Cancer Research 23 (15), 4212-4223, 2017
Mandates: US National Institutes of Health
Analysis of Circulating Tumor DNA to Predict Risk of Recurrence in Patients With Esophageal and Gastric Cancers
BM Huffman, VN Aushev, GL Budde, J Chao, F Dayyani, D Hanna, ...
JCO Precision Oncology 6, e2200420, 2022
Mandates: US National Institutes of Health
Risk factors, prevalence, and site concordance of human papillomavirus in high-risk Greek men.
S Tsikis, L Hoefer, G Bethimoutis, E Nicolaidou, V Paparizos, C Antoniou, ...
European journal of cancer prevention: the official journal of the European …, 2018
Mandates: US National Institutes of Health
Comprehensive Genomic Profiling (CGP)-Informed Personalized Molecular Residual Disease (MRD) Detection: An Exploratory Analysis from the PREDATOR Study of Metastatic Colorectal …
S Lonardi, H Nimeiri, C Xu, DR Zollinger, RW Madison, AD Fine, ...
International Journal of Molecular Sciences 23 (19), 11529, 2022
Mandates: Government of Italy, AIRC Foundation for Cancer Research in Italy
Serial Circulating Tumor DNA Detection Using a Personalized, Tumor-Informed Assay in Esophageal Adenocarcinoma Patients Following Resection
E Ococks, S Sharma, AWT Ng, A Aleshin, RC Fitzgerald, E Smyth
Gastroenterology 161 (5), 1705-1708. e2, 2021
Mandates: Cancer Research UK, UK Medical Research Council, UK Research & Innovation
420P Minimal residual disease detection and tracking tumour evolution using ctDNA in stage I-III colorectal cancer patients
TV Henriksen, N Tarazona, T Reinert, JA Carbonell-Asins, D Roda, ...
Annals of Oncology 31, S419-S420, 2020
Mandates: Danish Council for Independent Research, Danish Council for Strategic …
Publication and funding information is determined automatically by a computer program